Literature DB >> 19862464

Osteonecrosis of the jaw in patients receiving oral bisphosphonates.

Athanassios Kyrgidis, Konstantinos Vahtsevanos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19862464     DOI： 10.1007/s00198-009-1089-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  7 in total

1.  Osteonecrosis of the jaw among bisphosphonate users.

Authors:  Athanassios Kyrgidis; Anastassios Barbas
Journal:  Am J Med       Date:  2008-12       Impact factor: 4.965

2.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; Leon A Assael; Regina Landesberg; Robert E Marx; Bhoomi Mehrotra
Journal:  J Oral Maxillofac Surg       Date:  2009-05       Impact factor: 1.895

3.  Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients.

Authors:  Athanassios Kyrgidis; Konstantinos Vahtsevanos; Georgios Koloutsos; Charalampos Andreadis; Ioannis Boukovinas; Zisis Teleioudis; Anna Patrikidou; Stefanos Triaridis
Journal:  J Clin Oncol       Date:  2008-06-23       Impact factor: 44.544

Review 4.  Factors associated with osteonecrosis of the jaw among bisphosphonate users.

Authors:  Lisa M Hess; Joanne M Jeter; Marge Benham-Hutchins; David S Alberts
Journal:  Am J Med       Date:  2008-06       Impact factor: 4.965

5.  Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases.

Authors:  W Park; N-K Kim; M-Y Kim; Y-M Rhee; H J Kim
Journal:  Osteoporos Int       Date:  2009-05-30       Impact factor: 4.507

Review 6.  Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.

Authors:  Athanassios Kyrgidis; Stefanos Triaridis; Kostantinos Vahtsevanos; Kostantinos Antoniades
Journal:  Expert Rev Anticancer Ther       Date:  2009-08       Impact factor: 4.512

7.  Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.

Authors:  Konstantinos Vahtsevanos; Athanassios Kyrgidis; Evgenia Verrou; Eirini Katodritou; Stefanos Triaridis; Charalampos G Andreadis; Ioannis Boukovinas; Georgios E Koloutsos; Zisis Teleioudis; Kyriaki Kitikidou; Panagiotis Paraskevopoulos; Konstantinos Zervas; Konstantinos Antoniades
Journal:  J Clin Oncol       Date:  2009-10-05       Impact factor: 44.544
  7 in total
  5 in total

1.  Denosumab-related osteonecrosis of the jaws.

Authors:  A Kyrgidis; K A Toulis
Journal:  Osteoporos Int       Date:  2010-03-20       Impact factor: 4.507

2.  Osteonecrosis of jaw associated with bisphosphonate use.

Authors:  Ashu Rastogi; Vidya Rattan; Sanjay Kumar Bhadada
Journal:  Indian J Endocrinol Metab       Date:  2012-05

3.  Intermittent Parathyroid Hormone Injection Can Decrease Femoral Head Collapse in the Vascular Deprivation of Rat Femoral Head Model.

Authors:  Chih-Wei Chiang; Wei-Chuan Chen; Chian-Her Lee; Chih-Hwa Chen
Journal:  Indian J Orthop       Date:  2019 Mar-Apr       Impact factor: 1.251

4.  Targeted approaches in the treatment of osteoporosis: differential mechanism of action of denosumab and clinical utility.

Authors:  Loredana Cavalli; Maria Luisa Brandi
Journal:  Ther Clin Risk Manag       Date:  2012-06-11       Impact factor: 2.423

5.  Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws.

Authors:  D Yoshiga; Y Yamashita; I Nakamichi; T Tanaka; K Yamauchi; N Yamamoto; S Nogami; T Kaneuji; S Mitsugi; T Sakurai; H Kiyomiya; K Tominaga; Y Morimoto; T Takahashi
Journal:  Osteoporos Int       Date:  2013-01-31       Impact factor: 4.507
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.